IBRX: ImmunityBio, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 2,290.40
Enterprise Value ($M) 3,013.94
Book Value ($M) -590.48
Book Value / Share -0.67
Price / Book -3.88
NCAV ($M) -785.08
NCAV / Share -0.89
Price / NCAV -2.92

Profitability (mra)
Return on Invested Capital (ROIC) -1.75
Return on Assets (ROA) -1.02
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 2.05
Current Ratio 2.22

Balance Sheet (mrq) ($M)
Current Assets 109.16
Assets 303.76
Liabilities 894.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14.74
Operating Income -344.18
Net Income -413.56
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -391.24
Cash from Investing -12.25
Cash from Financing 281.63

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-29 1,968,394 6,143,341 32.04
2025-05-28 1,411,818 3,951,445 35.73
2025-05-27 2,316,564 6,979,532 33.19

(click for more detail)

Similar Companies
HLVX – HilleVax, Inc. HOWL – Werewolf Therapeutics, Inc.
HUMA – Humacyte, Inc. IDXX – IDEXX Laboratories, Inc.
IDYA – IDEAYA Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io